FDA Inspection 1229003 - University of Utah Cell Therapy and Regenerative Medicine - September 30, 2024

FDA Inspection 1229003 for University of Utah Cell Therapy and Regenerative Medicine on September 30, 2024. Classification: VAI.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1229003 for University of Utah Cell Therapy and Regenerative Medicine on September 30, 2024. Classification: VAI.

Violation Codes

21 CFR 1271.270(a)

21 CFR 1271.290(e)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

University of Utah Cell Therapy and Regenerative Medicine

Inspection Date

September 30, 2024

Product Type

Biologics

Office

Denver District Office

ID: 0c1d4c00-2750-4476-9d09-f6de4ff56463

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox